What is the current Lyme Disease Test Kit market size?

The current Lyme Disease Test Kit market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Lyme Disease Test Kit market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Lyme Disease Test Kit market?

Key drivers include rising incidence of Lyme disease and advancements in diagnostic technologies.

What are the major challenges facing the Lyme Disease Test Kit market?

Challenges include high costs, limited awareness, and stringent regulatory frameworks.

Which regions are leading the Lyme Disease Test Kit market?

North America and Europe are leading the market due to high prevalence and awareness.

Who are the top companies in the Lyme Disease Test Kit market?

Top companies include Abbott, Roche, and Siemens, offering innovative diagnostic solutions.

What future opportunities exist in the Lyme Disease Test Kit market?

Future opportunities include emerging markets, point-of-care testing, and molecular diagnostics.

How is technology impacting the Lyme Disease Test Kit market?

Technology advancements are improving test accuracy, speed, and accessibility, driving market growth.

What is the current regulatory landscape for the Lyme Disease Test Kit market?

The regulatory landscape is stringent, with FDA and CE markings required for market approval.

What is the future outlook for the Lyme Disease Test Kit market?

The future outlook is positive, with increasing demand and innovations driving market expansion.

Lyme Disease Test Kit Expansion Opportunities & Forecast Analysis 2033

Lyme Disease Test Kit by Application (Individual, Hospitals and Testing Institutions, Others), by Types (ELISA, IFA, Western Blotting, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Lyme Disease Test Kit Market Overview

The Lyme Disease Test Kit market refers to the industry involved in the development, manufacturing, and distribution of diagnostic kits used to detect Lyme disease, a bacterial infection caused by Borrelia burgdorferi. As the global healthcare industry continues to evolve, the Lyme Disease Test Kit market size is expected to witness significant growth, driven by increasing demand for accurate and reliable diagnostic solutions. The growth outlook for the Lyme Disease Test Kit market is positive, with a projected market size of approximately $1.4 billion by 2026, and a market forecast indicating a compound annual growth rate (CAGR) of 6.5% during the forecast period. The industry expansion is expected to be driven by advancements in technology, increasing awareness about Lyme disease, and growing demand for point-of-care diagnostic solutions.

Loading chart…

The Lyme Disease Test Kit market is expected to be driven by key forces such as technology shifts, including the development of more accurate and sensitive diagnostic tests, regulatory requirements, such as the need for FDA clearance, and consumer behavior, including increasing awareness about Lyme disease. The largest region for the Lyme Disease Test Kit market is North America, while the fastest-growing region is expected to be Europe. The market is expected to witness significant growth during the forecast period, driven by increasing demand for diagnostic solutions and advancements in technology.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Quidel Corporation; Fujirebio; ZEUS Scientific; IGeneX; Thermo Fisher Scientific; Oxford Immunotec Global PLC (PerkinElmer); BioMerieux; T2 Biosystems; Everlywell
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Lyme Disease Test Kit market is experiencing significant growth, driven by increasing awareness and diagnosis of Lyme disease. Understanding the market dynamics is crucial for stakeholders to navigate this complex landscape.

Growth Drivers2 items

Advancements in diagnostic technologies, such as point-of-care testing, are driving the growth of the Lyme Disease Test Kit market size by providing accurate and rapid results, thereby enhancing patient outcomes.

The growth forecast of the Lyme Disease Test Kit market is also fueled by the increasing prevalence of Lyme disease, particularly in regions with high tick populations, leading to a rise in demand for effective diagnostic solutions.

Restraints2 items

Stringent regulatory requirements and the need for Lyme Disease Test Kit market players to comply with these regulations are limiting the entry of new players and restraining market growth.

The high cost associated with the development and maintenance of advanced diagnostic technologies is another restraint, affecting the growth forecast of the Lyme Disease Test Kit market, particularly in resource-constrained settings.

Opportunities2 items

Emerging markets, particularly in Asia-Pacific and Latin America, present significant opportunities for the Lyme Disease Test Kit market due to their large, underserved populations and growing healthcare infrastructure.

The integration of artificial intelligence and machine learning in Lyme disease diagnostics is expected to enhance the accuracy and efficiency of testing, creating new opportunities for market players to develop innovative solutions.

Challenges2 items

Ensuring the accuracy and reliability of Lyme Disease Test Kit market products is a significant challenge due to the complex nature of Lyme disease and the potential for false positives or false negatives.

The Lyme Disease Test Kit market size is also affected by the lack of standardization in diagnostic testing, which can lead to variability in results and hinder the development of effective treatment strategies.

Market Segmentation

Loading chart…

The Lyme Disease Test Kit market can be segmented based on Application, which includes Clinical and Non-Clinical settings. The Clinical setting holds a significant share of the market, driven by the increasing demand for accurate diagnosis and treatment of Lyme disease. This segment contributes to the overall Lyme Disease Test Kit market size by providing a platform for the adoption of various test kits, including laboratory tests and point-of-care tests.

Another crucial aspect of Lyme Disease Test Kit segmentation is the Types of test kits available in the market. This includes subtypes such as Indirect Fluorescent Antibody (IFA), Enzyme-Linked Immunosorbent Assay (ELISA), and Polymerase Chain Reaction (PCR). Each subtype has its own set of advantages and disadvantages, catering to different needs and preferences of healthcare professionals and patients. Understanding these subtypes is essential for market players to develop targeted strategies and capitalize on the growing demand for Lyme disease test kits, ultimately influencing the market taxonomy.

Lyme Disease Test Kit Segmentation Breakdown9 items

Application

Individual

Hospitals and Testing Institutions

Others

Types

ELISA

IFA

Western Blotting

Others

Regional Insights

Loading chart…

The Lyme Disease Test Kit market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced diagnostic technologies, government policies supporting healthcare infrastructure development, and rising investments in research and development.

Key drivers for each region include: North America - high demographics awareness, established infrastructure, and mature ecosystem; Europe - stringent policies and regulations, high adoption rates, and significant investments in healthcare; Asia Pacific - large and growing demographics, increasing adoption of diagnostic technologies, and government support for infrastructure development; Latin America - growing demographics, improving infrastructure, and rising investments in healthcare; Middle East & Africa - increasing adoption of advanced diagnostic technologies, government policies supporting healthcare development, and rising investments in research and development.

The regional forecast indicates that the Lyme Disease Test Kit market will experience significant growth in the coming years, driven by increasing adoption of diagnostic technologies, government support, and rising investments in research and development. Understanding the key drivers and trends in each region is crucial for market players to develop effective strategies and capitalize on emerging opportunities.

Competitive Landscape

The Lyme Disease Test Kit market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers in this market include pricing, distribution, product innovation, certifications, and regulatory approvals. The Lyme Disease Test Kit competitive landscape is characterized by high competition, with players employing various strategies to differentiate themselves. Understanding the market structure and competitive dynamics is crucial for companies to navigate this complex landscape.

Companies in the Lyme Disease Test Kit market employ common strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, players face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have adopted distinct strategic focuses:

Quidel Corporation: regional expansion

Fujirebio: innovation pipeline

ZEUS Scientific: OEM tie-ups

IGeneX: premium pricing

Thermo Fisher Scientific: vertical integration

Oxford Immunotec Global PLC: local manufacturing

Key Lyme Disease Test Kit Companies9 items

Quidel Corporation

Fujirebio

ZEUS Scientific

IGeneX

Thermo Fisher Scientific

Oxford Immunotec Global PLC (PerkinElmer)

BioMerieux

T2 Biosystems

Everlywell

Market Ecosystem

The Lyme Disease Test Kit ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where OEMs and manufacturers integrate these components into test kits; and downstream, where channels and distributors deliver the final products to end users, including hospitals, clinics, and laboratories. The value created in this ecosystem is captured through the development, manufacturing, and distribution of accurate and reliable test kits.

Raw material/component suppliers — providing key components

OEMs / manufacturers — designing and producing test kits

Technology providers — developing diagnostic technologies

System integrators / EPCs — integrating test kits into larger systems

Distributors / channel partners — delivering products to end users

Regulators/standards bodies — setting testing and safety standards

End users / buyers — utilizing test kits for diagnostic purposes

In the Lyme Disease Test Kit ecosystem, control points are largely influenced by regulators and standards bodies, as they dictate the approval and adoption of new test kits. Dependency risks arise from input constraints, such as the availability of raw materials, and the need for regulatory approvals. Switching costs for end users can be significant due to the need for retraining and equipment updates. Furthermore, partnerships between manufacturers and distributors can impact the availability and accessibility of test kits. A thorough value chain analysis is necessary to understand these dynamics and how they vary by region, given diverse regulatory environments and market needs.

Recent Industry Insights

The Lyme Disease Test Kit industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Zybio and LabCorp, have focused on improving test kit sensitivity and specificity. Additionally, there have been notable mergers and acquisitions, including the acquisition of Immunetics by Oxford Immunotec, which has expanded the company's product portfolio in the Lyme disease testing market.

Furthermore, the industry has seen the launch of new products and technologies, such as the introduction of point-of-care test kits, which provide faster and more convenient diagnosis. Regulatory changes, including the FDA's updated guidelines for Lyme disease testing, have also impacted the market. These developments have contributed to a shift in consumer and enterprise trends, with increased demand for accurate and reliable test kits. Funding rounds and expansions have also been announced, with companies investing in research and development to improve test kit performance and accessibility, driving growth in the Lyme Disease Test Kit industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Lyme Disease Test Kit market. The market attractiveness is moderate, driven by increasing demand for early disease detection and diagnosis. The competitive intensity is high, with key players investing in research and development to improve test kit sensitivity and specificity. The long-term Lyme Disease Test Kit market outlook is promising, with growing awareness and adoption of diagnostic tests. The innovation landscape is characterized by advancements in technology, such as PCR and ELISA, which are expected to drive growth.

The demand–supply balance is expected to be stable, with manufacturers increasing production to meet growing demand. However, key risk factors include regulatory changes, supply chain disruptions, and intense competition. Overall, the market is expected to experience steady growth, driven by increasing demand for accurate and reliable diagnostic tests.

12 items

1. Executive Summary

2. Lyme Disease Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lyme Disease Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Lyme Disease Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Lyme Disease Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Lyme Disease Test Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Lyme Disease Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Lyme Disease Test Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Lyme Disease Test Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Lyme Disease Test Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Lyme Disease Test Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Lyme Disease Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lyme Disease Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lyme Disease Test Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Lyme Disease Test Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Lyme Disease Test Kit Market Competition by Key Manufacturers

9.1. Global Lyme Disease Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Lyme Disease Test Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Quidel Corporation

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Fujirebio

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ZEUS Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. IGeneX

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Thermo Fisher Scientific

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Oxford Immunotec Global PLC (PerkinElmer)

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. BioMerieux

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. T2 Biosystems

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Everlywell

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lyme Disease Test Kit Market

Figure 4: Global Lyme Disease Test Kit Market: Drivers

Figure 5: Global Lyme Disease Test Kit Market: Challenges

Figure 6: Global Lyme Disease Test Kit Market: Trends

Figure 7: Global Lyme Disease Test Kit Market: Opportunity

Figure 8: Global Lyme Disease Test Kit Market: Restraint

Figure 9: Global Lyme Disease Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Lyme Disease Test Kit Market Value (USD Million) By Region

Figure 19: Global Lyme Disease Test Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Lyme Disease Test Kit Market Value (USD Million) By Region

Figure 27: Global Lyme Disease Test Kit Market Share (%) By: Regions (2032)

Figure 28: Global Lyme Disease Test Kit Market Volume (K) By Region

Figure 29: Global Lyme Disease Test Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Lyme Disease Test Kit Market Value (USD Million) By Region

Figure 37: Global Lyme Disease Test Kit Market Share (%) By: Regions (2032)

Figure 38: Global Lyme Disease Test Kit Market Volume (K) By Region

Figure 39: Global Lyme Disease Test Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Lyme Disease Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lyme Disease Test Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lyme Disease Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Lyme Disease Test Kit Market Value (USD Million) By Region

Table 14: Global Lyme Disease Test Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Lyme Disease Test Kit Market Volume (K) By Region

Table 31: Global Lyme Disease Test Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Lyme Disease Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Lyme Disease Test Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Lyme Disease Test Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Quidel Corporation Basic Information And Sales Area

Table 52: Quidel Corporation. Products Portfolio

Table 53: Fujirebio Basic Information And Sales Area

Table 54: Fujirebio. Products Portfolio

Table 55: ZEUS Scientific Basic Information And Sales Area

Table 56: ZEUS Scientific. Products Portfolio

Table 57: IGeneX Basic Information And Sales Area

Table 58: IGeneX. Products Portfolio

Table 59: Thermo Fisher Scientific Basic Information And Sales Area

Table 60: Thermo Fisher Scientific. Products Portfolio

Table 61: Oxford Immunotec Global PLC (PerkinElmer) Basic Information And Sales Area

Table 62: Oxford Immunotec Global PLC (PerkinElmer). Products Portfolio

Table 63: BioMerieux Basic Information And Sales Area

Table 64: BioMerieux. Products Portfolio

Table 65: T2 Biosystems Basic Information And Sales Area

Table 66: T2 Biosystems. Products Portfolio

Table 67: Everlywell Basic Information And Sales Area

Table 68: Everlywell. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Lyme Disease Test Kit Market Value (USD Million) By Region

Table 78: Global Lyme Disease Test Kit Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global Lyme Disease Test Kit Market Volume (K) By Region

Table 95: Global Lyme Disease Test Kit Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Lyme Disease Test Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Quidel Corporation; Fujirebio; ZEUS Scientific; IGeneX; Thermo Fisher Scientific; Oxford Immunotec Global PLC (PerkinElmer); BioMerieux; T2 Biosystems; Everlywell
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory requirements and the need for Lyme Disease Test Kit market players to comply with these regulations are limiting the entry of new players and restraining market growth.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Lyme Disease Test Kit Segmentation Breakdown9 items

Application

Individual

Hospitals and Testing Institutions

Others

Types

ELISA

IFA

Western Blotting

Others

Regional Insights

Loading chart…

Competitive Landscape

Quidel Corporation: regional expansion

Fujirebio: innovation pipeline

ZEUS Scientific: OEM tie-ups

IGeneX: premium pricing

Thermo Fisher Scientific: vertical integration

Oxford Immunotec Global PLC: local manufacturing

Key Lyme Disease Test Kit Companies9 items

Quidel Corporation

Fujirebio

ZEUS Scientific

IGeneX

Thermo Fisher Scientific

Oxford Immunotec Global PLC (PerkinElmer)

BioMerieux

T2 Biosystems

Everlywell

Market Ecosystem

Raw material/component suppliers — providing key components

OEMs / manufacturers — designing and producing test kits

Technology providers — developing diagnostic technologies

System integrators / EPCs — integrating test kits into larger systems

Distributors / channel partners — delivering products to end users

Regulators/standards bodies — setting testing and safety standards

End users / buyers — utilizing test kits for diagnostic purposes

Recent Industry Insights

Analyst Overview

Table of Contents